Kontigo Care AB (publ) (KONT.ST) Research

Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Gambling, a digital application for tackling gambling addiction. Established in 2013, the firm maintains its primary operations in Uppsala, Sweden.

Market snapshot

Symbol
KONT.ST
Price
$1.51
Day change
+11.03%
Market cap
$53.2M
P/E ratio
-43.90x
52-week range
1.28-2.43
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • AcouSort AB (publ) (ACOU.ST)
  • Alligator Bioscience AB (publ) (ATORX.ST)
  • Scandinavian Real Heart AB (Publ) (HEART.ST)
  • Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
  • Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
  • OncoZenge AB (publ) (ONCOZ.ST)
  • ScandiDos AB (publ) (SDOS.ST)
  • Simris Alg AB (publ) (SIMRIS-B.ST)

Open Kontigo Care AB (publ) (KONT.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.